Nabilah Rahman serves as a Senior Biostatistician and Senior Manager at the Consortium for Clinical Research and Innovation, Singapore (CRIS) since September 2021, leading statistical analyses for multiple clinical trials. Nabilah also holds the position of Honorary Joint Research Associate at the Saw Swee Hock School of Public Health since July 2019. Prior experience includes roles at the National University Health System, contributing to population health research and evaluations, and at the Saw Swee Hock School of Public Health, focusing on health services research. Nabilah's earlier positions include a Research Officer at the Singapore Prison Service, where statistical training was implemented, as well as temporary roles in the Ministry of Education and People's Association. Nabilah earned a Master of Science and a Bachelor of Science with Honours in Statistics from the National University of Singapore.
This person is not in any teams
This person is not in any offices
Consortium for Clinical Research and Innovation, Singapore (CRIS)
The Consortium for Clinical Research and Innovation, Singapore (CRIS) was established in 2020 with the goal of strengthening synergies and developing strategies for national-level clinical research and translation programmes that are under the stewardship of the Ministry of Health. It is a subsidiary of the Ministry of Health Holdings (MOHH). CRIS brings together six key national R&D initiatives and clinical services, and facilitate synergistic collaborations among them. These initiatives include: - Singapore Clinical Research Institute (SCRI) - National Health Innovation Centre Singapore (NHIC) - Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) - Precision Health Research, Singapore (PRECISE) - Singapore Translational Cancer Consortium (STCC) - Cardiovascular Disease National Collaborative Enterprise (CADENCE) CRIS aims to make a positive difference to Singapore patients and researchers by ensuring that these clinical research platforms and programmes are at the cutting edge of capability development and innovation. This will be achieved through facilitated collaborations and enduring partnerships with research and biomedical entities and communities across the public sector and industry across Singapore.